About Sermorelin Research

What this site is

Sermorelin Research is an evidence board for the peer-reviewed literature on sermorelin (GHRH(1-29)): every finding pinned up, sourced, and read straight. It is a way of reading that record, not a service built on top of it. Nobody here runs a clinic or staffs one — no clinician answers, no diagnosis or treatment is offered, and no medical advice is given. Nothing is built, stocked, or sold; what hangs on the board is citations, not product.

The "research" in our name is a position we occupy relative to the literature — the bench-research and analytical register, not a claim to run experiments, dispense anything, or offer treatment. We read studies and lay them out as a hard-edged evidence board: one figure, one cell, one source.

How we handle the evidence

Every quantitative claim on this site is tied to a numbered citation in the full reference list, and we hold three lines firmly. We attribute drug-class findings to the molecule that actually produced them — body-composition and cognition data go to tesamorelin, bone-mineral data to the GHRP class, never silently to sermorelin. We state the regulatory history accurately: formerly FDA-approved for pediatric growth-hormone deficiency, withdrawn in 2008 for commercial reasons, now compounded as a Category 1 bulk substance under Section 503A. And we mark the gaps — where adult anti-aging and weight-loss evidence runs out, we say so rather than fill the space.

What we do not do

We do not recommend doses for humans, describe protocols to follow, or frame any study figure as a personal instruction. We do not name product brands, list sellers, or quote prices. We do not claim a physical address, a phone line, or a clinical team. Where research-user communities report anecdotes, we label them as anecdote, not evidence. The site exists to make the published sermorelin record legible and verifiable — nothing more, and nothing for sale.